Showing posts with label treatment related mortality. Show all posts
Showing posts with label treatment related mortality. Show all posts
Sunday, June 05, 2011
(discussion on stats) extract/s: (Avastin) Bevacizumab and Cancer Treatment-Related Mortality, June 8, 2011 — JAMA
plus Related letters Bevacizumab and Cancer Treatment-Related Mortality Cornelis J. A. Punt, Linda Mol, Miriam Koopman JAMA. 2011;305(22):2292.doi:10.1001/jama.2011.758 Extract Full Text Full Text (PDF) Bevacizumab and Cancer Treatment-Related Mortality Patricia B. Cerrito JAMA. 2011;305(22):2292.doi:10.1001/jama.2011.759 Extract Full Text Full Text (PDF) Bevacizumab and Cancer Treatment-Related Mortality—Reply Shenhong Wu, Vishal Ranpura, Sanjay Hapani JAMA. 2011;305(22):2292-2293.doi:10.1001/jama.2011.760 Extract Full Text Full Text (PDF)
Monday, February 07, 2011
abstract: Treatment-Related Mortality With (Avastin) Bevacizumab in Cancer Patients JAMA (alone vs combo)
Data Synthesis "A total of 10 217 patients with a variety of advanced solid tumors from 16 RCTs were included in the analysis...."
Subscribe to:
Posts
(
Atom
)
